Dan Rossignol: Difference between revisions
IntoThinAir (talk | contribs) new lawsuit section (edited with ProveIt) |
IntoThinAir (talk | contribs) →Research: another of his papers |
||
| Line 3: | Line 3: | ||
Rossignol received his MD from the [[Medical College of Virginia]] and completed his residency in [[family medicine]] at the [[University of Virginia]].<ref>{{cite web | url=http://www.danrossignolmd.com/ | title=Dan Rossignol, MD | accessdate=11 October 2013}}</ref> |
Rossignol received his MD from the [[Medical College of Virginia]] and completed his residency in [[family medicine]] at the [[University of Virginia]].<ref>{{cite web | url=http://www.danrossignolmd.com/ | title=Dan Rossignol, MD | accessdate=11 October 2013}}</ref> |
||
==Research== |
==Research== |
||
Rossignol has published 18 scientific papers, according to [[PubMed]]. However, his website states the number is in fact 44.<ref>http://www.rossignolmedicalcenter.com/</ref> He is best known for publishing randomized clinical trials of HBOT for children with autism, having originally proposed their use for the condition in a 2006 non-peer-reviewed paper in ''[[Medical Hypotheses]]''.<ref>{{cite doi|10.1016/j.mehy.2006.02.009}}</ref> These trials have usually concluded that it is safe and effective.<ref>{{cite doi|10.1186/1471-2431-9-21}}</ref><ref>{{cite doi|10.1186/1471-2431-7-36}}</ref> With regard to one such trial, published in 2009, Rossignol has said that "kids who receive the same number of sessions outside of research settings often remain better for longer [than the four week period during which their symptoms were monitored in the study]."<ref>{{cite web | url=http://www.scientificamerican.com/blog/post.cfm?id=can-hyperbaric-oxygen-therapy-help-2009-03-13 | title=Can hyperbaric oxygen therapy help autistic kids? | work=[[Scientific American]] | date=13 March 2009 | accessdate=11 October 2013 | author=Lite, Jordan}}</ref> Critics of his HBOT research include Peter Lipson, who has noted that his trials have mostly been published in [[BioMed Central]] journals, which is "devoted to rapid, flexible publication," Lipson says.<ref>{{cite web | url=http://www.sciencebasedmedicine.org/is-there-no-end-to-unscientific-treatments-for-autism/ | title=Is there no end to unscientific treatments for autism? | work=Science-Based Medicine | date=14 October 2008 | accessdate=11 October 2013 | author=Lipson, Peter}}</ref> Some of Rossignol's other research has focused on the prevalence of [[mitochondrial disease]] in autistic children, and has concluded that an association exists between the two.<ref>{{cite doi|10.1038/mp.2010.136}}</ref> With regard to this study, Cecilia Giulivi of the [[University of California, Davis]] agreed that it appeared from Rossignol's paper that there is indeed a higher incidence of mitochondrial disease among autistic individuals.<ref>{{cite web | url=http://www.medscape.com/viewarticle/736560 | title=Mitochondrial Dysfunction Linked to Autism | work=[[Medscape]] | date=31 January 2011 | accessdate=11 October 2013 | author=Brooks, Megan}}</ref> |
Rossignol has published 18 scientific papers, according to [[PubMed]]. However, his website states the number is in fact 44.<ref>http://www.rossignolmedicalcenter.com/</ref> He is best known for publishing randomized clinical trials of HBOT for children with autism, having originally proposed their use for the condition in a 2006 non-peer-reviewed paper in ''[[Medical Hypotheses]]''.<ref>{{cite doi|10.1016/j.mehy.2006.02.009}}</ref> These trials have usually concluded that it is safe, and that it may be effective, but that further study is needed before it can be said to have been proven effective.<ref>{{cite doi|10.1186/1471-2431-9-21}}</ref><ref>{{cite doi|10.1186/1471-2431-7-36}}</ref><ref>{{cite doi|10.1186/2045-9912-2-16}}</ref> With regard to one such trial, published in 2009, Rossignol has said that "kids who receive the same number of sessions outside of research settings often remain better for longer [than the four week period during which their symptoms were monitored in the study]."<ref>{{cite web | url=http://www.scientificamerican.com/blog/post.cfm?id=can-hyperbaric-oxygen-therapy-help-2009-03-13 | title=Can hyperbaric oxygen therapy help autistic kids? | work=[[Scientific American]] | date=13 March 2009 | accessdate=11 October 2013 | author=Lite, Jordan}}</ref> Critics of his HBOT research include Peter Lipson, who has noted that his trials have mostly been published in [[BioMed Central]] journals, which is "devoted to rapid, flexible publication," Lipson says.<ref>{{cite web | url=http://www.sciencebasedmedicine.org/is-there-no-end-to-unscientific-treatments-for-autism/ | title=Is there no end to unscientific treatments for autism? | work=Science-Based Medicine | date=14 October 2008 | accessdate=11 October 2013 | author=Lipson, Peter}}</ref> Some of Rossignol's other research has focused on the prevalence of [[mitochondrial disease]] in autistic children, and has concluded that an association exists between the two.<ref>{{cite doi|10.1038/mp.2010.136}}</ref> With regard to this study, Cecilia Giulivi of the [[University of California, Davis]] agreed that it appeared from Rossignol's paper that there is indeed a higher incidence of mitochondrial disease among autistic individuals.<ref>{{cite web | url=http://www.medscape.com/viewarticle/736560 | title=Mitochondrial Dysfunction Linked to Autism | work=[[Medscape]] | date=31 January 2011 | accessdate=11 October 2013 | author=Brooks, Megan}}</ref> |
||
==Lawsuit== |
==Lawsuit== |
||
In 2010, Rossignol was sued in [[Cook County Circuit Court]] by James Coman, who alleged that Rossignol, along with another family practice physician, Anjum Usman of [[Naperville]], had administered "dangerous and unnecessary experimental treatments", including [[chelation therapy]], to Coman's son, who was 7 years old at the time.<ref>{{cite web | url=http://www.chicagotribune.com/health/ct-met-autism-therapy-lawsuit-20100304,0,5271734.story | title=Doctors sued over ‘dangerous’ autism treatment | work=[[Chicago Tribune]] | date=4 March 2010 | accessdate=11 October 2013 | author=Callahan, Patricia}}</ref> |
In 2010, Rossignol was sued in [[Cook County Circuit Court]] by James Coman, who alleged that Rossignol, along with another family practice physician, Anjum Usman of [[Naperville]], had administered "dangerous and unnecessary experimental treatments", including [[chelation therapy]], to Coman's son, who was 7 years old at the time.<ref>{{cite web | url=http://www.chicagotribune.com/health/ct-met-autism-therapy-lawsuit-20100304,0,5271734.story | title=Doctors sued over ‘dangerous’ autism treatment | work=[[Chicago Tribune]] | date=4 March 2010 | accessdate=11 October 2013 | author=Callahan, Patricia}}</ref> |
||
Revision as of 22:22, 11 October 2013
Dan A. Rossignol, MD, FAAFP is a doctor and autism researcher who currently works at the International Child Development Resource Center in Melbourne, Florida, run by Jeff Bradstreet. He is well known for his research into and advocacy for the use of hyperbaric oxygen therapy as a treatment for autism.
Education
Rossignol received his MD from the Medical College of Virginia and completed his residency in family medicine at the University of Virginia.[1]
Research
Rossignol has published 18 scientific papers, according to PubMed. However, his website states the number is in fact 44.[2] He is best known for publishing randomized clinical trials of HBOT for children with autism, having originally proposed their use for the condition in a 2006 non-peer-reviewed paper in Medical Hypotheses.[3] These trials have usually concluded that it is safe, and that it may be effective, but that further study is needed before it can be said to have been proven effective.[4][5][6] With regard to one such trial, published in 2009, Rossignol has said that "kids who receive the same number of sessions outside of research settings often remain better for longer [than the four week period during which their symptoms were monitored in the study]."[7] Critics of his HBOT research include Peter Lipson, who has noted that his trials have mostly been published in BioMed Central journals, which is "devoted to rapid, flexible publication," Lipson says.[8] Some of Rossignol's other research has focused on the prevalence of mitochondrial disease in autistic children, and has concluded that an association exists between the two.[9] With regard to this study, Cecilia Giulivi of the University of California, Davis agreed that it appeared from Rossignol's paper that there is indeed a higher incidence of mitochondrial disease among autistic individuals.[10]
Lawsuit
In 2010, Rossignol was sued in Cook County Circuit Court by James Coman, who alleged that Rossignol, along with another family practice physician, Anjum Usman of Naperville, had administered "dangerous and unnecessary experimental treatments", including chelation therapy, to Coman's son, who was 7 years old at the time.[11]
Personal life
Rossignol is married. His wife's name is Lanier Rossignol; they have two children, both of whom have autism.[12][13]
References
- ^ "Dan Rossignol, MD". Retrieved 11 October 2013.
- ^ http://www.rossignolmedicalcenter.com/
- ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1016/j.mehy.2006.02.009, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1016/j.mehy.2006.02.009instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1186/1471-2431-9-21, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1186/1471-2431-9-21instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1186/1471-2431-7-36, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1186/1471-2431-7-36instead. - ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1186/2045-9912-2-16, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1186/2045-9912-2-16instead. - ^ Lite, Jordan (13 March 2009). "Can hyperbaric oxygen therapy help autistic kids?". Scientific American. Retrieved 11 October 2013.
- ^ Lipson, Peter (14 October 2008). "Is there no end to unscientific treatments for autism?". Science-Based Medicine. Retrieved 11 October 2013.
- ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1038/mp.2010.136, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1038/mp.2010.136instead. - ^ Brooks, Megan (31 January 2011). "Mitochondrial Dysfunction Linked to Autism". Medscape. Retrieved 11 October 2013.
- ^ Callahan, Patricia (4 March 2010). "Doctors sued over 'dangerous' autism treatment". Chicago Tribune. Retrieved 11 October 2013.
- ^ "About Us". ICDRC. Retrieved 11 October 2013.
- ^ "Dan Rossignol". Wisconsin Integrative Hyperbaric Center. Retrieved 11 October 2013.